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Secretory Cells of the Peripheral Pulmonary
Epithelium asTargets forToxic Agents
byGary E. R. Hook, and Richard P. DiAugustine:
The extraceliular lining of the pulmonary peripheral airways is of vital importance to the lung.
In this report, some aspects ofthe pulmonary extracellular lining and the epithelial cells believed
to be responsible for its formation and secretion have been briefly reviewed. The influence of a
number of toxic agents on the extracellular lining either directly or via those cells involved in its
formation indicates that the extracellular lining may be important in understanding numerous
toxic agent interactions with the lung.
The peripheral airways of the lung, that is, the
bronchioles and alveoli, are lined with an extra-
cellular layer of material (1, 2) which is essential
for the prevention of atelectasis. Under condi-
tions where the extracellular layer is absent,
reduced, or altered, breathing is impaired (3-8).
The nature of the extracellular lining is complex,
consisting primarilyofpolar lipids and proteins as
well as other materials such as water, inorganic
ions, and some low molecular weight organic mol-
ecules. The lipid components have received the
greatest attention from researchers, although
recently a number of the protein constitutents
have been identified. The origins of all the known
components of the extracellular layer have not
been elucidated; however, the secretory cells of
the peripheral airways have been implicated in
the production of some of the constituents. In
view of the essential nature of the extracellular
lining, the cells and processes responsible for its
production would appear to be of great impor-
tance to the lung and consequently should be of
considerable concern to the toxicologist. The se-
cretory cells of the peripheral airways could be
key sites through which many inhaled environ-
mental agents, both gaseous and particulate, ex-
ert their effects upon the lungs.
* Pharmacology Branch, National Institute of Environmen-
tal Health Sciences, Research Triangle Park, N.C. 27709.
In the discussion that follows, we will describe
some salient features of the peripheral airways
and the cells thought to be responsible for the for-
mation ofsome ofthe constituents ofthe extracel-
lular lining. In addition, we will focus attention
upon the response ofthis system to toxic agents.
The Extracellular Lining
All of the branches of the upper and lower pul-
monary airways have an extracellular lining. The
epithelium of the upper airways, including the
bronchi and trachea, is covered with a mucous
layer. The mucins that compose this layer are
thought to be secreted by goblet cells (Fig. 1) that
are part of the pseudostratified columnar epithe-
lium. The abundant cilia of this epithelium beat
continuously in such a manner as to move the
mucous layer, along with free cells and small par-
ticulates, up the respiratory tract. This "muco-
ciliary escalator" begins in the regions of the res-
piratory bronchioles. The response ofthe respira-
tory mucociliary system to irritants has been
previously reviewed (9, 10). The lower air-
ways consisting of bronchioles and alveoli do not
contain mucin-producing cells in their epithelium,
and consequently the extracellular lining is quite
different in composition from that of the upper
airways. Although the extracellular lining of the
lower airways may also be involved in the trans-
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FiIGURE 1. Longitudinal section of rabbit bronchial epithelium with part of the lamina propria (LP). The Epon-embedded section
was stained with toluidine blue and shows the pseudo-stratified columnar epithelium common to the upper airways. Cells are
attached to a basement membrane (BM). The basal cells (B) divide and apparently differentiate to form the ciliated cells (C)
and the mucus-secreting goblet cells (G). The apocrinic secretion process of the goblet cells is represented by the intense stain-
ing of the apical region of these cells. Typical histological patterns of the tracheo-bronchial epithelium in response to irritant
gases or particulates are loss ofcilia, basal cell hyperplasia, and excessive goblet cell secretion. (Magnification X1280).
port of particulate materials from the lung, its
primary function appears to be the stabilization
of the alveoli and bronchioles. The extracellular
lining appears to prevent the collapse of the pe-
ripheral airways by reducing surface tension at
the air-cell interface at low lung volumes. The
surfactant properties of the extracellular lining
have been reviewed extensively (11-14).
Electron micrographs of the extracellular lin-
ing overlying sections of alveolar type I cells are
shown in Figure 2. Preservation of the lining is
not easily achieved during fixation ofthe lung for
electron microscopy and perfusion of the fixative
through the vasculature is essential (2). General-
ly, the lining appears amorphous and granular,
although its appearance seems to depend upon
the fixation procedure and method of staining
used for its visualization under the electron mi-
croscope. Other electron micrographs have been
published in which a thin superficial osmiophilic
layer extends over an amorphous subphase (2,
15). The phospholipid-containing latticelike struc-
tures known as tubular myelin (16) seen at the
surface of the extracellular lining in Figure 2, are
often found in the alveoli. Their function within
the lining is not known.
The extracellular lining of the peripheral air-
ways is generally sampled by lavaging the lungs
with isotonic saline or a balanced salt solution via
the trachea. This process removes extracellular
material from both upper and lower airways; con-
sequently, interpretation ofanalyses made on the
lavage effluent must be made with caution. For
example, while it appears that most of the phos-
pholipid components of the lavage effluent arise
from the extracellular lining ofthe peripheral air-
ways, some minor components could arise from
the upper airways and their origin would be mis-
takenly attributed to the lower airways. In addi-
tion to extracellular components ofthe lining, the
lavage effluent contains alveolar macrophages
and other mononuclear cells. The cells can be
readily removed from the lavage effluent by dif-
ferential centrifugation.
Compositional analyses of the cell-free lavage
effluents vary considerably although most re-
ports agree that the major surface-active compo-
nent and the major phospholipid of the extracel-
lular lining is dipalmitoyl lecithin (17). Many
other minor lipid components (18-20) are also
found in pulmonary lavage effluents. The major
phospholipid components appear to be secreted
by the alveolar type II cell although considerable
controversy has been associated with this pointof
view. The controversy concerning the cellular
origins of pulmonary surfactant was initiated by
Environmental Health Perspectives 148FIGURE 2. Extracellular lining material (EL) overlying alveolar type I cells (rabbit). Tubular myelin (TM) figures are often found
in the extracellular liningofthe alveoli. (Magnification x61,560).
the observations of Niden (21) that the bronchi-
olar Clara cell may be secreting phospholipids
and that the type II cell might be involved in the
subsequent removal of phospholipids from the ex-
tracellular lining via a phagocytic process. Later
studies have been published purporting secretion
of surfactant phospholipids by the Clara cell (22,
23) as well as phagocytic activity of the type II
cells (24-26). However, many other studies haye
been made which neither support phospholipid
secretion by the Clara cell nor phagocytic activity
forthe type II cell.
The major protein component of pulmonary
lavage effluents is albumin which has been
shown, using immunochemical methods, to be a
normal constituent of the extracellular lining
(27). Similar immunochemical methods have been
used to show the presence of IgG at the lining
(28). Both albumin and IgG are probably found in
the respiratory tract as a result of transudation
of serum proteins from pulmonary capillaries.
Secretory IgA, which appears to have an impor-
tant antibacterial and antiviral function at the
mucous surface ofthe distal lung is reported to be
synthesized locally by plasma cells in the lung
lamina propia or near glandular epithelial ducts
(29, 30). Also, the IgA found in secretions differs
from serum IgA in molecular weight and composi-
tion. Other factors may be present in the extra-
cellular lining which assist in the protection ofthe
August 1976 149lung against certain bacteria. The bactericidal ac-
tivity of alveolar macrophages against S. aureus
appears to be stimulated in the presence of
alveolar lining material (31).
The Clara Cell
The nonciliated Clara cell (Fig. 3) is one of two
major cell types found within the bronchiolar epi-
thelium. The other major cell type is the ciliated
cell. The nucleus of the Clara cell is located
toward the base of the cell and the cytoplasm
bulges into the lumen ofthe bronchiole. A distinc-
tive feature of the rabbit Clara cell is the abun-
dance of smooth endoplasmic reticulum; rough
endoplasmic reticulum is very sparse. These cells
generally possess prominent Golgi and numerous
mitochondria. As with the murine lung Clara cell,
two types of mitochondria may be observed in
Clara cells from the rabbit. Many mitochondria
appear large and spherical with small and infre-
quent cristae, while others appear smaller and
elongated with numerous cristae.
The functions of the Clara cell within the bron-
chioles of the lung are, at present, poorly under-
stood, but considerable emphasis has been placed
upon its role as a secretory cell. Morphological
characteristics of the Clara cell indicate that the
cell is secretory but the nature of its secretions
and the manner in which secretion occurs has yet
to be unequivocally determined. Both merocrinic
and apocrinic secretory processes have been de-
scribed. The classic studies, published in 1937, of
Clara (32), after whom the nonciliated bron-
chiolar epithelial cell has come to be named, sug-
gested apocrinic secretion as a possible process
through which the Clara cell may contribute ma-
terials to the extracellular liningofthe peripheral
airways. Since then other investigators, using
more advanced microscopic techniques, have re-
ported similar observations (21-23, 33, 34). The
secretions have been described as mucoid (34),
nonmucoid (32), and surfactant (21, 22).
Merocrinic secretion of the cytoplasmic gran-
ules by the Clara cell has been considered a possi-
ble, if rarely observed, event (35, 36). The gran-
ules appearing as amorphous electron dense
bodies are often found concentrated in apical
regions of the Clara cell. The contents of these
cytoplasmic granules are not known but histo-
chemical studies indicate the presence of protein
and nonextractable phospholipid (35). Unlike the
lamellar bodies of the type II cell, the contents of
the Clara cell granules are not extractable by
chloroform-methanol mixtures and consequently
are unlikely to be a storage site for saturated
phospholipids ofthe extracellular lining (37).
The Type 11 Cell
In view of the large body of accumulated
evidence, there seems little doubt that the type II
cell is secretory. The type II cell is attached to
the basement membrane and is one of two major
epithelial cells located within the alveolus. The
type II cell often assumes a somewhat cuboidal
appearance and is easily distinguished from the
type I cell, whose highly attenuated cytoplasm is
spread over most ofthe basement membrane.
Unlike many other secretory cells, the Golgi
apparatus of the type II cell is not overly promi-
nent. The cytoplasm also contains mitochondria,
endoplasmic reticulum, and small vacuoles, none
of which lend morphological distinction to the
cell. Numerous microvilli are found on the free
surface of the cell and tight junctions exist where
the type II cell is in contact with type I cells. The
most distinctive feature of the type II cell is the
cytoplasmic concentric lamellar organelles which
are usually referred to as lamellar bodies (Fig. 4).
Lamellar bodies vary in size from approximately
0.25 to 3 ,u in diameter in the rabbit, and each one
is enclosed by a limiting unit membrane. The
bodies contain an osmiophilic substance of multi-
lamellated appearance. Originally thought to
derive from mitochondria (38-41), lamellar bodies
are now considered to be synthesized from multi-
vesicular bodies (42, 43). The type II cell is the
only cell in the normal lung where these struc-
tures may be seen.
In 1954, Macklin (44) suggested that material
may be secreted by the type II cell into the extra-
cellular lining. Many electron micrographs of
lamellar bodies, apparently in the process of be-
ing secreted, have since been published (43,
45-49). The secreted material is thought to be
pulmonary surfactant and the lamellar bodies are
considered to be storage sites of the surface-
active phospholipids. Cytochemical studies have
indicated the presence of phospholipids in lam-
ellar bodies (37, 50), and with the advent of
methods for the isolation ofthese structures from
lung homogenates a high phospholipid content
has been confirmed (51-53). The major phospho-
lipid of lamellar bodies is dipalmitoyl lecithin,
which is also the major surface-active phospholip-
id of the extracellular lining. The presence of
lamellar bodies in cloned rat alveolar type II cells
grown in culture is prima facie evidence for the
biosynthesis of surfactant phospholipids by this
epithelial cell (54).
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FIGURE 3. Bronchiolar Clara cell ofthe rabbit. Cytoplasmic granules (Gr)may be secreted by this cell (Magnification x20,520).
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FIGURE 4. Alveolar type II cell ofthe rabbit. Lamellar bodies (LB) are storage sites ofsurface-active phospholipids. (Magnification
x20,520).
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The emphasis placed here on the Clara cell and
the alveolar type II cell should in no way distract
from the important role many cells might have in
elaborating important secretions for the respira-
tory tract. Beneath the pulmonary epithelium lie
many other types of cells, such as mast cells,
leukocytes, and plasma cells, which can respond
to immunologic, inflammatory, or toxic stimuli.
ToxicAgents
The system, consisting of secretory cells and
the extracellular lining, that we have briefly
described is, of importance to the lung for such
functions as gaseous diffusion, compliance, de-
fense, and clearance. The location of this system
is such that it should be vulnerable to the enor-
mous variety of toxic agents ranging from partic-
ulate solids to gases. The surface area of the
human respiratory tract is approximately 70 m2,
with a similar order of magnitude for the surface
area of the underlying capillary bed. Thus, the
lining system offers high accessibility to not only
inhaled toxicants but also those which reach the
lungs via the vascular circulation.
Many reagents are known to affect the lungs
adversely but in most cases the target cells have
never been elucidated. Interactions of toxic
chemicals with secretory cells and the extra-
cellular lining have been noted but few have been
studied in detail. Interactions of particular im-
portance are those which could produce altera-
tions in the extracellular lining and hence impair-
ment ofpulmonary function.
Relationships between altered morphology of
secretory cells and the functional capacity of the
extracellular lining have not been established,
although it may be assumed that degenerative
alterations in the appearance of type II cells and
perhaps Clara cells might affect their secretory
abilities. Carbon dioxide, for instance, has been
shown to produce hyalinelike membranes in ani-
mals with a concomitant depletion or vacuoli-
zation of the lamellar bodies (55). These effects,
however, could be due to C02-induced acidemia.
Also, alterations in the populations of these cells
might affect the capacity for the formation, if not
the quality, of the extracellular lining. Unfortu-
nately the mechanisms which maintain the extra-
cellular lining in dynamic equilibrium are not
known and consequently toxic agents could affect
those processes involved in removal of the lining
as well as those synthetic and secretory aspects
which we attributed to type II and Clara cells.
The recognition of target cells of toxic agents is
extremely difficult when electron microscopy is
the principal tool involved in the diagnosis, since
cellular degeneration may not become apparent
until events have progressed well beyond the ini-
tiallesion at the biochemical level.
The interaction of toxic chemicals with cellular
constituents and morphological alterations are
not necessarily confined to the same locus. The
alterations in populations of a particular cell type
may be initiated by toxic lesions produced in cell
populations different from that observed to
change. This appears to be especially true of the
type II cells whose proliferation subsequent to
type I cell injury is considered part of the normal
repair process. For example, type II cells which
are relatively resistant to the effects of the oxi-
dant gases, oxygen, ozone, and nitrogen dioxide,
nevertheless proliferate in response to injury in-
flicted upon the type I cell by these gases (56-59).
Proliferative responses by the type II cell have
been observed following exposure of animals to
numerous toxicants such as cadmium (60), busul-
phan (61), bleomycin (62), heroin (63), silica (64),
and urethane (65). However, with most toxic
agents reasons for the proliferative response of
the type II cell are not clear. Only the oxidant
gases have been sufficiently well studied for it to
be concluded with confidence that the type II cell
responds to type I cellinjury.
The proliferation oftype II cells may also occur
in the absence of apparent injury to type I cells.
In radiation pneumonitis induced by inhalation of
239PuO2 particles, type II cells appear highly sen-
sitive to injury by a-radiation, whereas type I
cells show signs of damage only in the terminal
stages of the disease (66). The proliferation of
type II cells seen in radiation pneumonitis may be
aresponse totypeIIcell, ratherthan typeIcellin-
jury. Proliferation of type II cells in response to
type II cell injury may be part of the repair proc-
ess since other toxic agents such as busulphan
(61) and bleomycin (62) cause type II cell damage
as well as proliferation ofthis cell.
Proliferation of Clara-like cells in the bronchi-
oles has been reported following exposure of
animals to ozone (67) and nitrogen dioxide (68),
and it is tempting to speculate that possible bron-
chiolar epithelial repair functions for the Clara
cell exist which are similar to those defined for
the alveolar type II cell. Clara cell proliferation
has also been observed in response to other toxic
compounds such as 4-nitroquinoline 1-oxide (69)
and urethane (70), although with these particular
compounds the alterations may be related to
their carcinogenic activities: both of these com-
August 1976 153pounds can produce epithelial tumors in the lung.
Clara cells shows signs of injury very soon after
the injection of adrenalin (71). The type of injury,
characterized by bleb or balloonlike structures at
the apical regions of the cells, may not be uncom-
mon with the Clara cell. The responses of Clara
cells to adrenalin appear remarkably similar to
processes which have been interpreted by others
as apocrinic secretion. In fact, earlier studies of
adrenalin-induced pulmonary edema (72) were in-
terpreted to indicate enhanced secretion by Clara
cells. However, as Wang, et al. (71) pointed out
bleblike processes are not confined to Clara cells
and similar effects may also be seen in type II
cells and ciliated cells. Similar kinds of altera-
tions in Clara cells are produced by inhalation of
formaldehyde aerosols (73) and ammonia vapor
(74).
Although many compounds appear to affect se-
cretory cells of the peripheral airways, their ef-
fects on the extracellular lining are less well
characterized. In most cases, alterations in the
extracellular lining can only be implied from
studies of electron micrographs. The manner in
which the lining is affected and the extent to
which its functions are impaired has received
very little attention. Extreme reductions in
pulmonary compliance associated with heroin-
induced edema (63) and oxygen toxicity (75) and
the appearance of hyaline membranes similar to
those found in premature infants with respira-
tory distress syndrome suggest that the extracel-
lular lining may have been severely altered
although other mechanisms are also possible.
Edema fluid which is often present in lungs ex-
posed to toxic materials further complicates the
issue, since edema fluid can affect the surfactant
properties of the extracellular lining (76). How-
ever, absence of extracellular lining may also
cause edema and, consequently, reasons for toxi-
cant effects on the extracellular lining are dif-
ficult to determine.
From light and electron micrographs, the pres-
ence of unusual components in the peripheral air-
ways generally indicates at least compositional
changes in the extracellular lining. Proteinaceous
materials in alveoli such as that seen following in-
halation of aluminum dust (77) and silica (64) ap-
pear to be tolerated reasonably well, since res-
piratory distress does not accompany the induced
lesions. Other toxic materials such as ozone (78),
paraquat (79), and certain anesthestics (80) also
appear to affect adversely the extracellular lining
as studied by lavage.
Perhaps directly related to secretory cells and
their secretions are the effects of a number of
drugs which produce lipidosislike morphological
alterations in the lung as well as other organs
(81). The list of these drugs (81) includes a
number of tricyclic antidepressants, antihista-
minic, antihypercholesterolemic, and anorectic
drugs. Common to all of these drugs is the pro-
duction of lamellar structures similar to those
found in type II cells, in a number of nonpul-
monary tissues as well as some non-type II pul-
monary cells, such as alveolar macrophages and
Clara cells (82, 83). Chlorcyclizine appears to pro-
duce not only lamellar structures in cells not nor-
mally found to contain such structures but also
hyperplasia and hypertrophy of the type II cell
and the accumulation of lamellar body-related
materials in the lumen of the alveoli. Reasons for
these effects appear to be related to the amphi-
pathic nature of drugs and their ability to asso-
ciate with phospholipids. More precise reasons
have not been elucidated, but it would appear
that these compounds could be directly affecting
lamellar body formation and/or secretion by the
type II cell.
We have considered briefly the capacity of
some toxic agents to affect the extracellular lin-
ing as well as those cells which may be responsi-
ble for many of its components. Reasons for the
susceptibility of the alveolar regions of the lung
to so many diverse toxic agents are not clear.
Certainly, it seems unlikely that cellular proc-
esses unique to the lung offer specific sites for in-
teractions with a vast number of toxicants. How-
ever, the extracellular lining could help explain
the unusual susceptibility ofalveolar cells to toxic
agents were the lining directly involved in medi-
ating the toxic effects. The extracellular lining
being rich in phospholipids, may serve to store
and concentrate lipophilic or amphipathic agents
until sufficient quantities have accumulated to af-
fect those metabolically highly active cells with
which the lining is in intimate contact.
We wish to thank Linda B. Gilmore, Frederick A. Talley,
and Drs. B. N. Gupta and E. E. McConnell for assistance in the
preparation ofthe micrographs.
REFERENCES
1. Gil, J., and Weibel, E. R. Extracellular lining of bronchi-
oles after perfusion-fixation of rat lungs for electron
microscopy. Anat. Rec. 169: 185 (1971).
2. Weibel, E. R., and Gil, J. Electron microscopic demonstra-
tion of an extracellular duplex layer of alveoli. Respir.
Physiol. 4: 42 (1968).
3. Brumley, G. W., Hodson, W. A., and Avery, M. E., Lung
phospholipids and surface tension correlations in infants
with and without hyaline membrane disease and in adults.
Pediatrics 40: 13 (1967).
154 Environmental Health Perspectives4. Adams, F. H., et al. Surface properties and lipids from
lungs of infants with hyaline membrane disease. J. Pediat.
66: 357 (1967).
5. Finley, T. N., et al. Pulmonary surface tension in experi-
mental atelectasis. Am. Rev. Resp. Dis. 89: 372 (1964).
6. Giammona, S. T., et al. Effects of pulmonary artery liga-
tion on pulmonary surfactant and pressure-volume charac-
teristics ofdoglung. Circ. Res. 18: 683 (1966).
7. Chernick, V., Hodson, W. A., and Greenfield, L. J. Effect
of chronic pulmonary artery ligation on pulmonary me-
chanics and surfactant. J. Appl. Physiol. 21: 1315 (1966).
8. Gardner, R. E., Finley, T. N., and Tooley, W. H. The ef-
fect of cardiopulmonary bypass on surface activity of lung
extracts. Bull. Soc. Int. Chir. 21:542 (1962).
9. Yeager, H. Tracheobronchial secretions. Am. J. Med. 50:
493 (1971).
10. Reid, L. Evaluation of model systems for study of airway
epithelium, cilia, and mucus. Arch. Intern. Med. 126: 428
(1970).
11. Pattle, R. E. Surface lining of lung alveoli. Physiol. Rev.
45: 48 (1965).
12. Pattle, R. E. Surface tension and the lining of the lung
alveoli. In: Advances in Respiratory Physiology. C. G.
Caro, Ed., Edward Arnold Ltd., London, England, 1966, p.
83.
13. Heinemann, H. 0. Surfactant of the lung. Adv. Int. Med.
14: 83 (1968).
14. Goerke, J. Lung surfactant. Biochim. Biophys. Acta 344:
241 (1974).
15. Kaibara, M. and Kikkawa, Y. Osmiophilia of the saturated
phospholipid, dipalmitoyl lecithin, and its relationship to
the alveolar lining layer of the mammalian lung. Am. J.
Anat. 123: 61 (1971).
16. Weibel, E. R., Kistler, G. S., and Tondury, G. A sterologi-
cal electron microscope study of "tubular myelin figures"
in alveolar fluids ofrat lungs. Z. Zellforsch. 69: 418 (1966).
17. Brown, E. S. Isolation and assay of dipalmitoyl lecithin in
lungextracts. Am. J. Physiol. 207: 402 (1964).
18. Morgan, T. E., Finley, T. N., and Fialkow, H. Comparison
of the composition and surfact activity of "alveolar" and
whole lung lipids in the dog. Biochim. Biophys. Acta 106:
403 (1965).
19. Body, D. R. The phospholipid composition of pig lung sur-
factant. Lipids 6: 625 (1971).
20. Rooney, S. A., Canavan, P. M., and Motoyama, E. K. The
identification of phosphatidylglycerol in the rat, rabbit,
monkey, and human lung. Biochim. Biophys. Acta 360: 56
(1974).
21. Niden, A. H. Bronchiolar and large alveolar cell in pulmo-
nary phospholipid metabolism. Science 158: 1323 (1967).
22. Etherton, J. E., Conning, D. M., and Corrin, B. Autora-
diographical and morphological evidence for aprocrine
secretion of dipalmitoyl lecithin in the terminal bronchiole
ofmouse lung. Am. J. Anat. 138: 11 (1973).
23. Smith, P., Heath, D., and Moosavi, H. The Clara cell.
Thorax 29: 147 (1974).
24. Casarett, L. J., and Milley, P. S. Alveolar reactivity
following inhalation of particles. Health Phys. 10: 1003
(1964).
25. Boren, H. G. Pulmonary response to inhaled carbon: a
model oflung injury. Yale J. Biol. Med. 40: 364 (1968).
26. Corrin, B. Phagocytic potential ofpulmonary alveolar epi-
thelium with particular reference to surfactant metabo-
lism. Thorax 24: 110 (1969).
27. Bignon, J., et al. Ultrastructural immunoperoxidase dem-
onstration of autologous albumin in the alveolar capillary
membrane and in the alveolar lining material in normal
rats. J. Cell Biol. 64: 503 (1975).
28. Bignon, J., et al. Immunoelectron microscopic and immu-
nochemical demonstrations of serum proteins in the
alveolar lining material of the rat lung. Am. Rev. Resp.
Dis. 113: 109 (1976).
29. DeCoteau, W. E. The role of secretory IgA in defense of
the distal lung. Ann. N. Y. Acad. Sci. 221: 214 (1974).
30. Hand, W. L., and Cantey, J. R. Antibacterial mechanisms
of the lower respiratory tract. I. Immunoglobulin synthe-
sis and secretion. J. Clin. Invest. 53: 354 (1974).
31. LaForce, F. M., Kelly, W. J., and Huber, G. L. Inactiva-
tion of Staphylococci by alveolar macrophages with pre-
liminary observations on the importance of alveolar lining
material. Am. Rev. Resp. Dis. 108: 784 (1973).
32. Clara, M. Zur Histobiologie des Bronchalepithels. Z.
Mikr.-Anat. Forsch. 41: 21 (1937).
33. von Hayek, H. The Human Lung. Translated by V. E.
Krahl. Hafnes Publishing Co., Inc., New York, 1960.
34. von Hayek, H. Cellular structure and mucous activity in
the bronchial tree and alveoli. In: Pulmonary Structure
and Function, Ciba Foundation Symposium, 1961.
35. Cutz. E., and Conen, P. E. Ultrastructure and cytochemis-
try ofClaracells. Am. J. Pathol. 62: 127 (1971).
36. Kuhn, C., Callaway, L. A., and Askin, F. B. The formation
ofgranules in the bronchiolar Clara cells ofthe rat. 1. Elec-
tron microscopy. J. Ultrastruct. Res. 49: 387 (1974).
37. Askin, F. B., and Kuhn, C. The cellular origin of pulmo-
nary surfactant. Lab. Invest. 25: 260 (1971).
38. Kisch, B. Electron microscopic investigation of the lungs.
(capillaries and specific cells). Expt. Med. Surg. 13: 101
(1955).
39. Schulz, H., Elektronenoptische Untersuchungen der nor-
malen Lunge und der Lunge bei Mitralstenose. Virchow's
Arch. 328: 582 (1956).
40. Woodside, G. L., and Dalton, A. J. The ultrastructure of
lung tissue from newborn and embryo mice. J. Ultra-
struct. Res. 2: 28 (1958).
41. Klaus, M., et al. Alveolar epithelial cell mitochondria as
source of the surface-active lung lining. Science 137: 750
(1962).
42. Sorokin, S. P. A morphologic and cytochemical study on
the great alveolar cell. J. Histochem. Cytochem. 14: 884
(1966).
43. Kuhn, C. Cytochemistry of pulmonary alveolar epithelial
cells. Am. J. Pathol. 53: 809 (1968).
44. Macklin, C. C. The pulmonary alveolar mucoid film and
the pneumonocytes. Lancet 1954-I: 1099 (1954).
45. Bensch, K., Schaefer, K., and Avery, M. E. Granular
pneumonocytes: electron microscopic evicence of their ex-
ocrinic function. Science 145: 1318 (1964).
46. Hatasa, K., and Makamura, T. Electron microscopic obser-
vations of lung alveolar epithelial cells of normal young
mice, with special reference to formation and secretion of
osmiophilic lamellar bodies. Z. Zellforsch. 68: 266 (1965).
47. Smith, D. S., Smith, U., and Ryan, J. W. Freeze-fractured
lamellar body membranes of the rat lung great alveolar
cell. Tissue and Cell 4: 457 (1972).
48. Leeson, T. S., and Leeson, C. R. Osmiophilic lamellated
bodies and associated material in lung alveolar spaces. J.
Cell Biol. 28: 577 (1966).
49. Blumcke, S., et al. Ultrastructure of lamellar bodies of
Type II pneumonocytes after osmium-zinc impregnation.
J. Ultrastruct. Res. 42: 417 (1973).
50. Dermer, G. B. The pulmonary surfactant content of the in-
clusion bodies found within Type II alveolar cells. J.
Ultrastruct. Res. 33: 306 (1970).
51. DiAugustine, R. P. Lung concentric laminar organelles:
hydrolase activity and compositional analysis. J. Biol.
Chem. 249: 584 (1974).
August 1976 15552. Gil, J., and Reiss, 0. K. Isolation and characterization of
lamellar bodies and tubular myelin from rat lung homoge-
nates. J. Cell Biol. 58: 152 (1973).
53. Rooney, S. A., Page-Roberts, B. A., and Motoyama, E. K.
Role of lamellar inclusions in surfactant production:
studies on phospholipid composition and biosynthesis in
rat and rabbit lung subcellular fractions. J. Lipid Res. 16:
118 (1975).
54. Douglas, W. H. J., and Kaign, M. E. Clonal isolation ofdif-
ferentiated rat lungcells. In Vitro 10: 230 (1974).
55. Schaefer, K. E., Avery, M. E., and Bensch, H. Time course
of changes in surface tension and morphology of alveolar
epithelial cells in CO2-induced hyaline membrane disease.
J. Clin. Invest. 43: 2080 (1964).
56. Plopper, C. G., Dungworth, D. L., and Tyler, W. S. Pul-
monary lesions in rats exposed toozone. Am. J. Pathol. 71:
375 (1973).
57. Kapanci, Y. et al. Pathogenesis and reversibility of the
pulmonary lesions of oxygen toxicity in monkeys. II.
Ultrastructural and morphometric studies. Lab. Invest.
20: 101 (1969).
58. Evans, M. J. et al. Renewal of alveolar epithelium in the
rat following exposure to NO2. Am. J. Pathol. 70: 175
(1973).
59. Adamson, I. Y. R., and Bowden, D. H. The Type 2 cell as
progenitor ofalveolar epithelial regeneration. Lab. Invest.
30: 35 (1974).
60. Palmer, K. C., Snider, G. L., and Hayes, J. A. Cellular pro-
liferation induced in the lung by cadmium aerosol. Am.
Rev. Resp. Dis. 112:173 (1975).
61. Littler, W. A., et al. Busulphan lung. Thorax 24: 639
(1969).
62. Perez-Guerra, F., et al. Acute bleomycin lung. Am. Rev.
Resp. Dis. 106: 909 (1972).
63. Addington, W. W., et al. The pulmonary edema of heroin
toxicity-an example of the stifflung syndrome. Chest 62:
199 (1972).
64. Heppleston, A. G., Fletcher, K., and Wyatt, I. Changes in
the composition of lung lipids and the "turnover" of
dipalmitoyl lecithin in experimental alveolar lipo-protein-
osis induced by inhaled quartz. Brit. J. Exp. Pathol. 55:
384 (1974).
65. Kaufman, S. Alterations in cell proliferation in mouse lung
following urethane exposure. Am. J. Pathol. 68: 317
(1972).
66. Sanders, C. L., Adee, R. R., and Jackson, T. A. Fine struc-
ture of alveolar areas in the lung following inhalation of
239PuO2 particles. Arch. Environ. Health 22: 525 (1971).
67. Penha, P. D., and Werthamer, S. Pulmonary lesions in-
duced by long-term exposure to ozone. II. Ultrastructure
observations of proliferative and regressive lesions. Arch.
Environ. Health 29: 282 (1974).
68. Stephens, R. J., Freeman, G., and Evans, M. J. Early
response of lungs to low levels of nitrogen dioxide. Arch.
Environ. Health 24: 160 (1972).
69. Terav, D., and Otsu, H. Special susceptibility-of Clara cells
of the murine terminal bronchiole to 4-nitroquinoline 1-
oxide: an electron microscopic observation. Gann 64: 179
(1973).
70. Kauffman, S. L. Alteration in cell proliferation in mouse
lung following urethane exposure. II. Effects ofchronic ex-
posure on terminal bronchiolar epithelium. Amer. J.
Pathol. 64: 531 (1971).
71. Wang, N. S., et al. Ultrastructural changes of Clara and
Type II alveolar cells in adrenalin-induced pulmonary
edema in mice. Amer. J. Pathol. 62: 237 (1971).
72. Kisch, B. Electron microscopy oflungs in acute pulmonary
oedema. Exp. Med. Surg. 16: 17 (1958).
73. Roth, J. The Clara cells and the pulmonary surfactant sys-
tem. Exp. Pathol. 8: 305 (1973).
74. Niden, H. H., and Yamada, E. Y. Some observations on
the fine structure and function of the nonciliated bronchi-
olar cells. In: VIth International Congress on Electron
Microscopy, Kyoto 1966, Maruzen, Tokyo, 1966, Vol. 11, p.
599.
75. Clark, J. M., and Lambertsen, C. J. Pulmonary oxygen
toxicity: a review. Pharmacol. Rev. 23: 37 (1971).
76. Said, S. I., et al. Pulmonary surface activity in induced
pulmonary edema. J. Clin. Invest. 44: 458 (1965).
77. Gross, P., et al. Pulmonary reaction to metallic aluminum
powders. Arch. Environ. Health 26: 227 (1973).
78. Shimasaki, H., et al. Alteration of lung lipids in ozone ex-
posed rats. Biochem. Biophys. Res. Commun. 68: 1256
(1976).
79. Manktelow, B. W. The loss of pulmonary surfactant in
paraquat poisoning. Brit. J. Exp. Pathol. 48: 366 (1967).
80. Pattle, R. E., Schock, C., and Battensby, J. Some effects of
anaesthetics on lung surfactant. Brit. J. Anaesthesia. 44:
1119 (1972).
81. Lullmann-Rauch, R., and Reil, G. H. Chlorphentermine-
induced lipidosislike ultrastructural alterations in lungs
and adrenal glands ofseveral species. Toxicol. Appl. Phar-
macol. 30: 408 (1974).
82. Lullmann-Rauch, R., et al. The ultrastructure of rat lung
canges induced by an anorectic drug (chlorphentermine).
Virchow's Arch. B. Zellpathol. 11: 167 (1972).
83. Hruban, Z., Slesers, A., and Aschenbrenner, J. Pulmo-
nary intra-alveolar histiocytosis induced by drugs. Tox-
icol. Appl. Pharmacol. 26: 72 (1973).
156 Environmental Health Perspectives